Effectiveness and Healthcare Cost of Adding Trastuzumab to Standard Chemotherapy for First-Line Treatment of Metastatic Gastric Cancer: A Population-Based Cohort Study

A randomized clinical trial showed that trastuzumab, added to traditional chemotherapy, significantly improved overall survival in human epidermal growth factor receptor 2 (HER2)-overexpressing metastatic gastric cancer patients. This population-based study aimed at evaluating both the clinical and...

Descripción completa

Detalles Bibliográficos
Autores principales: Franchi, Matteo, Tritto, Roberta, Torroni, Lorena, Reno, Chiara, La Vecchia, Carlo, Corrao, Giovanni
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7352495/
https://www.ncbi.nlm.nih.gov/pubmed/32630517
http://dx.doi.org/10.3390/cancers12061691

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7352495/
https://www.ncbi.nlm.nih.gov/pubmed/32630517
http://dx.doi.org/10.3390/cancers12061691

Ejemplares similares